Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.

Gilbert AR, Pinget C, Bovet P, Cornuz J, Shamlaye C, Paccaud F.

Tob Control. 2004 Jun;13(2):190-5.

2.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

3.

Cost effectiveness analysis of smoking cessation interventions.

Shearer J, Shanahan M.

Aust N Z J Public Health. 2006 Oct;30(5):428-34. Review.

PMID:
17073223
4.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
5.

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP.

Thorax. 2010 Aug;65(8):711-8. doi: 10.1136/thx.2009.131631. Review.

PMID:
20685746
6.

Smoking cessation interventions in clinical practice.

Cornuz J.

Eur J Vasc Endovasc Surg. 2007 Oct;34(4):397-404. Epub 2007 Aug 3. Review.

7.
8.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
9.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

10.

The costs of smoking and the cost effectiveness of smoking-cessation programs.

Elixhauser A.

J Public Health Policy. 1990 Summer;11(2):218-37. Review.

PMID:
2114423
11.

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N.

Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S26-37. Review.

PMID:
12369228
12.

Current developments in behavioral interventions for tobacco cessation.

Murthy P, Subodh BN.

Curr Opin Psychiatry. 2010 Mar;23(2):151-6. doi: 10.1097/YCO.0b013e328336653f. Review.

PMID:
20061954
14.

Adapting smoking cessation interventions for developing countries: a model for the Middle East.

Maziak W, Eissenberg T, Klesges RC, Keil U, Ward KD.

Int J Tuberc Lung Dis. 2004 Apr;8(4):403-13. Review.

PMID:
15141730
15.

The economics of smoking and cardiovascular disease.

Lightwood J.

Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):39-78. Review.

PMID:
12920700
16.

[Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review].

Aumann I, Rozanski K, Damm K, Graf von der Schulenburg JM.

Gesundheitswesen. 2016 Oct;78(10):660-671. Epub 2015 May 8. Review. German.

PMID:
27784123
17.

The cost-effectiveness of substance abuse treatment.

Barnett PG.

Curr Psychiatry Rep. 1999 Dec;1(2):166-71. Review.

PMID:
11122920
18.

Pharmacological approach to smoking cessation.

Prignot J.

Eur Respir J. 1989 Jun;2(6):550-60. Review.

PMID:
2663534
19.

Impact and cost-effectiveness of smoking interventions.

Tsevat J.

Am J Med. 1992 Jul 15;93(1A):43S-47S. Review.

PMID:
1497003
20.

The human and financial costs of smoking.

Leistikow BN.

Clin Chest Med. 2000 Mar;21(1):189-97, x-xi. Review.

PMID:
10763099

Supplemental Content

Support Center